Clinical Trial Update: Postmarketing Surveillance Study of Atrovent® Inhaletten® in Chronic Obstructive Airways Disease

View source ↗

Summary

This document reports a completed postmarketing surveillance study of Atrovent Inhaletten for chronic obstructive pulmonary disease, sponsored by Boehringer Ing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Atrovent Inhaletten (ipratropium bromide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED